COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION

Show other versions (1)

<p><strong>Background.</strong> For prevention of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists (such as warfarin), antiplatelet therapy (such a...

Full description

Bibliographic Details
Main Authors: A. V. Rudakova, V. A. Parfenov
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
фибрилляция предсердий
новые пероральные антикоагулянты
анализ затраты-эффективность
апиксабан
варфарин
ацетилсалициловая кислота
Online Access:http://www.rpcardio.ru/jour/article/view/233

Internet

http://www.rpcardio.ru/jour/article/view/233

Similar Items